Search research articles
Contact Us
Filters
Showing results (451-460 of 544) with videos related to
Page
of 55
Sort By:
Journal of Food Protection
|
April 13, 2018
Contamination by Meat Juice When Shopping for Packages of Raw Poultry
Fur-Chi Chen, Sandria Godwin, Delores Chambers, et al.
Clinical Gerontologist
|
May 17, 2018
Implementation and Evaluation of a Life Narrative Interview Program for Medical Inpatients
Bruce Rybarczyk, Andrea Shamaskin-Garroway, Autumn Lanoye, et al.
Experimental Eye Research
|
August 16, 2024
Melanopsin in the human and chicken choroid
Christian Platzl, Alexandra Kaser-Eichberger, Andrea Trost, et al.
Cancer Research
|
December 20, 2007
MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells
Takeshi Kawano, Masaki Ito, Deepak Raina, et al.
Cancer Biology & Therapy
|
July 2, 2010
Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein
Li Yin, Rehan Ahmad, Michio Kosugi, et al.
Journal of the American Veterinary Medical Association
|
October 2, 2009
Detection of a large unnamed Babesia piroplasm originally identified in dogs in North Carolina in a dog with no history of travel to that state
Patricia J Holman, Brianna B Backlund, Angela L Wilcox, et al.
Blood
|
March 26, 2005
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412
Joseph D Growney, Jennifer J Clark, Jennifer Adelsperger, et al.
Science (New York, N.Y.)
|
December 15, 2022
Runners-up
Elizabeth Pennisi, Erik Stokstad, Ann Gibbons, et al.
Molecular Cancer Research : MCR
|
June 24, 2010
Combining the FLT3 inhibitor PKC412 and the triterpenoid CDDO-Me synergistically induces apoptosis in acute myeloid leukemia with the internal tandem duplication mutation
Rehan Ahmad, Suiyang Liu, Ellen Weisberg, et al.
Journal of Translational Medicine
|
September 12, 2015
Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis
Catriona Jamieson, Robert Hasserjian, Jason Gotlib, et al.
Page
of 55
Search research articles
Search
Showing results (451-460 of 544) with videos related to
Sort By:
Page
of 55
Journal of Food Protection
|
April 13, 2018
Contamination by Meat Juice When Shopping for Packages of Raw Poultry
Fur-Chi Chen, Sandria Godwin, Delores Chambers, et al.
Clinical Gerontologist
|
May 17, 2018
Implementation and Evaluation of a Life Narrative Interview Program for Medical Inpatients
Bruce Rybarczyk, Andrea Shamaskin-Garroway, Autumn Lanoye, et al.
Experimental Eye Research
|
August 16, 2024
Melanopsin in the human and chicken choroid
Christian Platzl, Alexandra Kaser-Eichberger, Andrea Trost, et al.
Cancer Research
|
December 20, 2007
MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells
Takeshi Kawano, Masaki Ito, Deepak Raina, et al.
Cancer Biology & Therapy
|
July 2, 2010
Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein
Li Yin, Rehan Ahmad, Michio Kosugi, et al.
Journal of the American Veterinary Medical Association
|
October 2, 2009
Detection of a large unnamed Babesia piroplasm originally identified in dogs in North Carolina in a dog with no history of travel to that state
Patricia J Holman, Brianna B Backlund, Angela L Wilcox, et al.
Blood
|
March 26, 2005
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412
Joseph D Growney, Jennifer J Clark, Jennifer Adelsperger, et al.
Science (New York, N.Y.)
|
December 15, 2022
Runners-up
Elizabeth Pennisi, Erik Stokstad, Ann Gibbons, et al.
Molecular Cancer Research : MCR
|
June 24, 2010
Combining the FLT3 inhibitor PKC412 and the triterpenoid CDDO-Me synergistically induces apoptosis in acute myeloid leukemia with the internal tandem duplication mutation
Rehan Ahmad, Suiyang Liu, Ellen Weisberg, et al.
Journal of Translational Medicine
|
September 12, 2015
Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis
Catriona Jamieson, Robert Hasserjian, Jason Gotlib, et al.
Page
of 55